# Nacuity Pharmaceuticals, Inc. — Form D

Nacuity Pharmaceuticals, Inc. of FORT WORTH, TX, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-27. The offering totals $10.0M, of which $7.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-06-27
- Form: D
- Accession: 0001250853-17-000059
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $7.3M
- Remaining: $2.7M
- Minimum investment: $25K
- Investors: 102
- Date of first sale: 2017-06-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-289536

## Issuer

- Name: Nacuity Pharmaceuticals, Inc.
- CIK: 0001690279
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: FORT WORTH CLUB BLDG., FORT WORTH, TX, 76102
- Phone: 817-336-3000

## Officers, directors & promoters (23)

| Name | Role | Location |
| --- | --- | --- |
| Michael Wall | Executive Officer | Fort Worth, TX |
| Robin Steele | Director | Fort Worth, TX |
| David Wohlberg | Director | Fort Worth, TX |
| David Wohlberg | Executive Officer | Fort Worth, TX |
| Rusty Kelley | Director | Fort Worth, TX |
| Gerald Cagle | Director | Fort Worth, TX |
| Jami Kern | Executive Officer | Fort Worth, TX |
| Benjamin Yerxa | Director | Fort Worth, TX |
| Emmett Cunningham, Jr. | Director | Fort Worth, TX |
| Halden Conner | Director | Fort Worth, TX |
| Halden Conner | Executive Officer | Fort Worth, TX |
| Charles Lieser | Executive Officer | Fort Worth, TX |
| Robert Ruffolo | Director | Boston, MA |
| Robin Steel | Director | Fort Worth, TX |
| Isaac Michael Blech | Director | New York, NY |
| Charles Michael Lieser | Executive Officer | Fort Worth, TX |
| G. Michael Wall, Ph.D. | Executive Officer | Fort Worth, TX |
| Dr. Gerald D Cagle | Director | Fort Worth, TX |
| David J Wohlberg | Director | Los Angeles, CA |
| William Halden Conner | Director | Fort Worth, TX |
| William Halden Conner | Executive Officer | Fort Worth, TX |
| Richard Michael Chin, M.D. | Director | San Francisco, CA |
| Sanford J Hillsberg | Director | Los Angeles, CA |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-12-30](https://search.stillhousedata.com/formd/0001690279-25-000002) | D | $30.0M | $8.4M |
| [2022-01-03](https://search.stillhousedata.com/formd/0001690279-22-000001) | D/A | $17.4M | $11.6M |
| [2021-03-30](https://search.stillhousedata.com/formd/0001690279-21-000003) | D | $11.0M | $3.2M |
| [2017-07-20](https://search.stillhousedata.com/formd/0001250853-17-000065) | D/A | $10.0M | $9.2M |
| [2016-12-08](https://search.stillhousedata.com/formd/0001250853-16-000186) | D | $2.5M | $2.0M |

## More

- [CIK 1690279 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1690279&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001250853-17-000059.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.